Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults

NACompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

November 22, 2021

Primary Completion Date

March 24, 2023

Study Completion Date

April 25, 2023

Conditions
Nasal Congestion
Interventions
DEVICE

Azeol spray nasal

Azeol Spray Nasal is a nasal spray intended to reduce the nasal congestion due to rhinitis, rhinosinusitis and colds which is marketed. The ID is conforming to the European Union (EU) legislation and is bearing the CE-mark. The ID is manufactured by PILEJE S.A.S (France).

DEVICE

Placebo nasal spray

with the same characteristics of appearance and packaging as Azéol Spray Nasal without the active ingredients

Trial Locations (2)

21000

CEN Nutriment, Dijon

44800

Biofortis - Unité d'investigation clinique, Saint-Herblain

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioFortis

OTHER

lead

Larena SAS

INDUSTRY